← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

1,908

Price

$0

Filed

Mar 2

Insider

Name

Poulton Jeffrey V.

Title

EVP, Chief Financial Officer

CIK

0001782962

Roles

Officer

Transaction Details

Transaction Date

2026-02-27

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

61,710

Footnotes

Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program. | These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. | On February 27, 2023, the reporting person was granted 5,724 restricted stock units that vest ratably on each of the first, second and third anniversaries of the Grant Date. On February 27, 2026, the third and final tranche of restricted stock units from the February 27, 2023 grant vested and was released, as reported on this Form 4. | The restricted stock units vest ratably in three installments, with one third vesting on each of the first, second and third anniversaries of the grant date.

Filing Info

Accession No.

0001735276-26-000040

Form Type

4

Issuer CIK

0001178670

Poulton Jeffrey V.'s History

Date Ticker Type Value
2026-03-04 ALNY $36K
2026-03-04 ALNY $35K
2026-03-04 ALNY $74K
2026-03-04 ALNY $99K
2026-03-04 ALNY $121K
2026-03-04 ALNY $265K
2026-03-04 ALNY $95K
2026-03-04 ALNY $73K
2026-03-02 ALNY A $0
2026-03-02 ALNY $21K

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06